Differences in the detection of cyclo-oxygenase 1 and 2 proteins in symptomatic and asymptomatic carotid plaques

British Journal of Surgery

Volumn 88, Issue 7, 2001, Pages 951-957

  Wijeyaratne, S M ^a   Abbott, C R ^a   Homer Vanniasinkam, S ^a   Mavor, A I D ^a   Gough, M J ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 ANTIBODY; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 ANTIBODY; EOSIN; HEMATOXYLIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; CONTROLLED STUDY; EXTERNAL CAROTID ARTERY; FEMALE; HUMAN; INTERNAL CAROTID ARTERY; MALE; MORPHOLOGY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STAINING; SURGICAL TECHNIQUE; SYMPTOM;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CAROTID ARTERY DISEASES; COHORT STUDIES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENZYME TESTS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; OBSERVER VARIATION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0035678884     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0007-1323.2001.01817.x     Document Type: Article

References (38)

1. Consensus statement on the management of patients with asymptomatic atherosclerotic carotid bifurcation lesions
2. Relationship between the regional and national incidence of transient ischaemic attack and stroke and performance of carotid endarterectomy
3. A prospective study of acute cerebrovascular disease in the community: The Oxfordshire community stroke project, 1981-1986. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage
4. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST)
5. Beneficial effects of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis
6. Endarterectomy for asymptomatic carotid artery stenosis
7. Asymptomatic internal carotid artery stenosis defined by ultrasound and the risk of subsequent stroke in the elderly. The cardiovascular health study
8. Duplex ultrasonography and selection of patients for carotid endarterectomy; plaque morphology or luminal narrowing?
9. The role of plaque morphology and diameter reduction in the development of new symptoms in asymptomatic carotid arteries
10. Characterization of symptomatic and asymptomatic carotid plaques using high-resolution real-time ultrasonography
11. The symptomatic carotid plaque
12. Macrophage accumulation within the cap of carotid atherosclerotic plaques is associated with the onset of cerebral ischaemic events
13. 2 synthesis blocks interstitial collagenase and 92-kd Type IV collagenase/gelatinase production by the human monocytes
14. Human vascular smooth muscle cell-monocyte interactions and metalloproteinase secretion in culture
15. Monocyte prostaglandins inhibit procollagen secretion by vascular smooth muscle cells: Implications for plaque stability
16. Inhibition of human arterial smooth muscle cell growth by human monocyte/macrophages: A co-culture study
17. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
18. Angiogenesis and the atherosclerotic carotid plaque: An association between symptomatology and plaque morphology
19. Prostaglandin endoperoxidase synthase, why two isoforms?
20. Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages
21. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions
22. Expression of cyclo-oxygenase-2 in human atherosclerotic carotid arteries
23. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
24. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
25. Differential inhibition of prostaglandin endoperoxide synthase (cycloxygenase) isoenzymes by aspirin and other non-steroidal antiinflammatory drugs
26. Cyclo-oxygenase-2 in vascular smooth muscle
27. Regulation of cyclooxygenase-2 expression in aortic smooth muscle cells
28. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man
29. Nonsteroidal antiinflammatory drugs inhibit cyclooxygenase-2 enzyme activity but not mRNA and protein expression in human macrophages
30. Cyclooxygenase-1 and 2-dependent prostacyclin formation in patients with atherosclerosis
31. Functional coupling of cyclooxygenase 1 and 2 to discrete prostanoid synthases in liver macrophages
32. Pharmacological analysis of cyclooxygenase-1 in inflammation
33. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: Implications for gastrointestinal toxicity
34. Expression of cyclooxygenase-1 and 2 in the human prostate
35. Cyclooxygenase knockout mice: Models for elucidating isoform specific functions
36. Cyclooxygenase-deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis
37. Asymptomatic carotid atherosclerosis study investigators. Baseline silent cerebral infarction in the asymptomatic carotid atherosclerosis study